Abstract
Dr Douglas Clarkson looks at how developments in medical screening techniques are showing promise in the identification and monitoring of central nervous system degenerative diseases such as Alzheimer's disease.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have